Congress in Spain were a major feature of research news last week, including those from Pfizer on it ponsegromab in cancer ...

On Friday, the US Food and Drug Administration approved UK pharma major AstraZeneca’s (LSE: AZN) FluMist for self- or ...

The European Commission has conditionally approved the marketing application submitted by Ipsen for Iqirvo (elafibranor) 80mg ...

The UK’s MHRA has approved Takeda’s Fruzaqla (fruquintinib) for metastatic colorectal cancer (CRC) in adults who have not ...

US presidential election, health policy will remain a key issue for pharma. Both Donald Trump and Kamala Harris have ...

Achilles Therapeutics has announced it will discontinue its tumor-infiltrating lymphocyte (TIL)-based clonal neoantigen T ...

The European Medicines Agency’s (EMA) advisory committee the CHMP has adopted a positive opinion for a label update of Danish ...

Novo Nordisk has announced positive Phase IIa results for monlunabant, a small molecule oral CB1 inverse agonist for obesity.

Today, the US Food and Drug Administration approved Miplyffa (arimoclomol), an oral medication for the treatment of ...

Basilea Pharmaceutica (SIX: BSLN) announced that the Biomedical Advanced Research and Development Authority (BARDA), part of ...

Committee for Human Medicinal Products (CHMP) recommended approval of five novel medicines at its September meeting ...

Leslie Orne, president and CEO of Trinity Life Sciences, emphasizes the importance of corporate efficiency in the highly ...